Prostate cancer (PCa) is the second most commonly diagnosed neoplasm in men worldwide, with the highest incidence in the Western countries largely due to the widespread use of prostate-specific antigen (PSA) testing [1]. This evidence concerns the gene KLK3 and neoplasm.